| ? | (A;A) (A;C) (C;C) | 28 |
|---|
 |
[PMID 22321278] [Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy]
[PMID 17048007] Association of warfarin dose with genes involved in its action and metabolism.
[PMID 18574025] The largest prospective warfarin-treated cohort supports genetic forecasting.
[PMID 19300499] A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.
[PMID 22178823] [Distribution of variant alleles association with warfarin pharmacokinetics and pharmacodynamics in the Han population in China].
| GET Evidence
|
| rs4917639
|
| aa_change
|
|
| aa_change_short
|
|
| impact
|
pharmacogenetic
|
| qualified_impact
|
Insufficiently evaluated pharmacogenetic
|
| overall_frequency
|
0.1875
|
| summary
|
|
